Saturday, February 25, 2023 8:30 AM - 2:45 PM Studio 7 Chair: Julie Shroeter, Alan Johnson
A session focused on aquaculture drug approval progress updates and associated research, presented by a variety of representatives from government, academic, and private sector partners.
8:30 AM Jennifer Matysczak
FDA CENTER FOR VETERINARY MEDICINE’S AQUACULTURE STRATEGIC PLAN AND CENTER UPDATES
ANTIBACTERIAL ACTIVITY OF SEA URCHINS (ARBACIA PUNCTULATE AND STRONGYLOCENTROTUS DROEBACHIENSIS) BODY WALL EXTRACTS AGAINST GRAM POSITIVE AND GRAM NEGATIVE PATHOGENIC BACTERIA